The updated list of strategic enterprises consists of 21 pharmaceutical company
The government Commission on sustained development of the Russian economy approved the inclusion of 662 companies in the branch list of strategic enterprises. Thus, the list of strategic enterprises currently includes more than 1.1 thousand organizations. All companies from the list can count on state support and subsidies.
The updated list consists of 21 pharmaceutical company: “GENERIUM”, “R-Pharm”, “FarmFirma “Soteks”, “ERKAFARM”, “North star”, “Nanolek”, “NEO-FARM”, “PHARMACY CHAIN 36,6”, “Moscow endocrine plant”, “Active component”, “VERTEX”, “GEROPHARM”, “Groteks”, “Polisan”, FSUE Spbniivs FMBA of Russia, “pharmasyntez”, “Synthesis”, “Obolenskoe”, “BIOCAD”, Kanonfarma prodakshn”, “Pharmstandard”.
The previous version of the list was approved in early April, 2020, then the list included seven of the pharmaceutical companies (JSC Binnopharm, OJSC “Biosintez”, JSC “Pharmstandard”, LLC “Neo-farm”, JSC “R-Pharm”, JSC “Joint-stock Kurgan society of medical drugs and products “Synthesis”, JSC “PROTEK”).
